|  | TnT |  |  | TnT | |
---|---|---|---|---|---|---|
Time | Group | n | ng/L | Group | n | ng/L |
Baseline | Placebo | 40 | 45 (14–295) | All | 81 | 45 (10–343) |
ARB | 41 | 46 (10–343) |  |  |  | |
1 week | Placebo | 38 | 48 (17–303) | All | 77 | 47 (10–305 |
ARB | 39 | 47 (10–305) |  |  |  | |
3 months | Placebo | 35 | 59 (18–927) | All | 70 | 51 (10–927) |
ARB | 35 | 48 (10–271) |  |  |  | |
6 months | Placebo | 32 | 50 (17–267) | All | 62 | 52 (10–1642) |
ARB | 30 | 56 (10–1642) |  |  |  | |
9 months | Placebo | 32 | 46 (16–249) | All | 61 | 48 (10–249) |
ARB | 29 | 52 (10–214) |  |  |  | |
12 months | Placebo | 29 | 50 (16–210) | All | 54 | 49 (13–451) |
ARB | 25 | 49 (13–451) |  |  |  |